Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • The cGAS-STING pathway: DNA sensing in health and disease (Jun 2026)
    • Neurodegeneration (Mar 2026)
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Polyamine sequestration of 2′3′-cGAMP constrains intercellular transmission and STING engagement to subvert antitumor immunity
Yunjin Ma, Chunyuan Zhao, Jiacheng Guo, Yue Fu, Wei Wang, Jiangong Zhang, Kun Zhao, Xiangbo Meng, Zhongshang Yuan, Chengjiang Gao, Mutian Jia, Ying Qin, Hui Song, Wei Zhao
Yunjin Ma, Chunyuan Zhao, Jiacheng Guo, Yue Fu, Wei Wang, Jiangong Zhang, Kun Zhao, Xiangbo Meng, Zhongshang Yuan, Chengjiang Gao, Mutian Jia, Ying Qin, Hui Song, Wei Zhao
View: Text | PDF
Research Article Immunology Metabolism

Polyamine sequestration of 2′3′-cGAMP constrains intercellular transmission and STING engagement to subvert antitumor immunity

  • Text
  • PDF
Abstract

The cyclic dinucleotide 2′3′–cyclic guanosine monophosphate–adenosine monophosphate (2′3′-cGAMP) serves as a central immunotransmitter that propagates stimulator of interferon gene–dependent (STING-dependent) innate immunity across tissues; however, how microenvironmental metabolites regulate its spatiotemporal dynamics remains unknown. Here, we identified polyamines (spermine and spermidine) as critical rheostats controlling 2′3′-cGAMP functionality. Mechanistically, polyamines sequestered 2′3′-cGAMP into polymer-like aggregates, blocking intercellular propagation and suppressing intracellular STING activation by reducing ligand-receptor binding affinity. Deficiency of spermidine and spermine N1-acetyltransferase 1 (SAT1), the rate-limiting enzyme in polyamine catabolism, elevated polyamine levels to entrap extracellular 2′3′-cGAMP and inhibit STING activation. Synergistic administration of endogenous 2′3′-cGAMP with SAT1 stabilizer N1,N11-diethylnorspermine restored 2′3′-cGAMP bioavailability and STING signaling, facilitated type I interferon responses to reprogram immunologically suppressive tumors into immunologically active states and enhanced tumor clearance. Our study established polyamine–cGAMP interactions as a critical spatiotemporal regulatory mechanism for tissue-level immunity, providing a unified model for metabolite-mediated cyclic GMP-AMP synthase–STING (cGAS-STING) regulation across diseases.

Authors

Yunjin Ma, Chunyuan Zhao, Jiacheng Guo, Yue Fu, Wei Wang, Jiangong Zhang, Kun Zhao, Xiangbo Meng, Zhongshang Yuan, Chengjiang Gao, Mutian Jia, Ying Qin, Hui Song, Wei Zhao

×

Figure 6

Sat1 deficiency attenuates STING-driven antitumor immunity.

Options: View larger image (or click on image) Download as PowerPoint

Sat1 deficiency attenuates STING-driven antitumor immunity.
(A) Schemat...
(A) Schematic of the BMDM–tumor cell coculture system. Images were created with BioRender. (B) ELISA analysis of IFN-β and CXCL10 secretion in Sat1+/+ or Sat1–/– BMDM coculture with B16F10, followed by 2′3′-cGAMP stimulation. (C and D) ELISA analysis in Cgas–/– or Sting1–/– BMDMs coculture with B16F10 pretreated with polyamines, then treated with doxorubicin or not. (E) Experimental scheme for Sat1+/+ or Sat1–/– mice bearing subcutaneous tumors. (F and G) LC‑MS/MS, quantitative liquid chromatography‑tandem mass spectrometry quantification of extracellular 2′3′-cGAMP (F) or spermine and spermidine (G) in Sat1+/+ or Sat1–/– mice at day 13 after inoculation with B16F10 (n = 5 per condition). (H and I) Tumor volume curve (H; n = 8 per condition) or tumor weight (I; n = 7 per condition) of Sat1+/+ or Sat1–/– mice after B16F10 inoculation treated with 2′3′-cGAMP. (L–O) Sat1+/+ or Sat1–/– mice at day 13 after inoculation with B16F10. Quantification of CD8+ T cell (J) or MDSC (N) populations per gram of tumor from tumor-bearing mice (n = 7 per condition). Flow cytometry analysis showing the percentage of intratumoral CD8+ T cells expressing GZMB (K), IFN-γ (L), and TNF-α (M) (n = 6 per condition) or CD4+FOXP3+ Tregs (O) (n = 7 per condition) in B16F10 tumor. Statistical significance was determined using an unpaired 2-sided t test, and adjustments were made for multiple comparisons in B–D, F, G, and I–O or 2-way ANOVA in H. The data are shown as the mean ± SEM. *P <0.05, **P <0.01. Similar results were obtained from 3 independent experiments. Put, putrescine; Spm, spermine; Spd, spermidine; I.T., intratumoral injection; APC, allophycocyanin; PE, phycoerythrin; FITC, fluorescein isothiocyanate.

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts